The Bob Harrington Show

 
 

The Bob Harrington Show

  • The Career Pivot: Leaving Clinical Medicine   Bob Harrington talks to two former colleagues who made a mid- and senior-career switch to pharma and digital tech, respectively. How did they make this decision and what advice do they have for others?
  • Top Cardiology Trials of 2022   Trials on heart failure, hypertension and lipid-lowering drugs, and the evolution of antithrombin and antiplatelet therapy are discussed in part 2 of cardiologists Bob Harrington and Mike Gibson's annual review.
  • 2022 in Review Through a Cardiology Lens   In part 1 of their annual review, cardiologists Bob Harrington and Mike Gibson discuss in-person meetings, wearables and AI, COVID lessons for medical research, and the growth of RCTs from China.
  • What Do We Know About Long COVID: A Cardiovascular Focus   Drs Bob Harrington and Betty Raman discuss the cardiovascular impact and long-term sequelae of COVID-19, the potential biology behind multisystem effects, and ongoing research.
  • Do Older vs Younger Docs Treat AF Differently?   Do cardiologists from the AFFIRM generation treat AF less aggressively than the EAST-AFNET generation? Bob Harrington and Jonathan Piccini discuss this and upcoming trials on atrial fibrillation.
  • A Diversity Scorecard to Teach, Not Shame, Cardiology to Do Better   Dr Bob Harrington talks with Drs Michelle Albert and Eldrin Lewis about the Association of Black Cardiologists' diversity scorecard for cardiovascular training programs.
  • The Medical Student Teaching Medicine About Structural Racism   Robert A. Harrington interviews LaShyra Nolen, a medical student and the 2021 recipient of the American Medical Student Association's Racial Justice in Medicine Award.
  • New Revascularization Guidelines: Key Points and Controversies   Bob Harrington interviews fellow cardiologist Jacqueline Tamis-Holland, vice chair of the recent ACC/AHA revascularization guidelines. She lets us inside the process and responds to the controversy.
  • COVID-19 and the Heart: Is Cardiology Ready?   Robert Harrington, MD, interviews Ziyad Al-Aly, MD, about his recent paper in Nature Medicine focused on the long-term cardiovascular effects of COVID-19.
  • COVID and CV Public Health Trials 2021   Trials on lowering salt consumption and treating hypertension in the community impressed Drs Harrington and Gibson in this discussion of the best public health research of 2021.
  • Top Cardiology Trials of 2021   Drs Harrington and Gibson provide their annual roundup of what they consider the key cardiovascular trials of 2021.
  • Meet the Doc Who Put Hydroxychloroquine on Trial in COVID-19   Drs Bob Harrington and Martin Landray discuss the importance of randomization for testing therapeutics and the opportunities the COVID-19 pandemic provided.
  • A Tale of Medical Mysteries Unraveled by Genetic Detectives   A genomics giant with a family history of heart disease and an Olympic athlete accused of cheating are just two of the medical mysteries that were unraveled by DNA analysis.
  • COVID and the Athlete's Heart   When is it safe to return to play after having COVID? Bob Harrington and Manesh Patel discuss our evolving understanding of how SARS-CoV-2 affects the hearts of athletes and weekend warriors.
  • 2020 Wrap-up: COVID-19's Effects on Cardiology   Bob Harrington and Mike Gibson continue their review of 2020, discussing the 'riddle wrapped in an enigma' that was the COVID-19 pandemic.
  • Top Cardiology Trials of 2020 in Review   The annual tradition continues as did cardiology research despite a pandemic. Trials on fish oils, statins, SGLT2 inhibitors, and antiplatelets are among the selections of Drs Harrington and Gibson.
  • Pandemic Publishing: Speed vs Quality Control   Three editors of cardiology journals -- Drs Harrington, Yancy, and Nallamothu -- discuss the challenges of maintaining quality during the COVID-19 surge in submissions.
  • Thrombosis in COVID-19: What We Know and How to Treat   Hematologist Mary Cushman discusses arterial and venous thrombosis issues with SARS-CoV-2 and the role of anticoagulation.
  • Pandemic: 'Another Earthquake' Exposing Health Inequities   Bob Harrington asks Michelle Albert why mortality rates are so high in minority communities, and whether COVID-19 will lead to meaningful changes in health and social inequities.
  • Yes, There Is a Role for Poetry and Fiction in a Pandemic   'They fancy themselves free. And no one will ever be free so long as there are pestilences,' wrote Camus in 'The Plague', which Abraham Verghese sees as relevant to our collective experience of COVID-19.